Order Article Reprints

Shurtleff AC, Trefry JC, Dubey S, Sunay MME, Liu K, Chen Z, Eichberg M, Silvera PM, Kwilas SA, Hooper JW, et al. rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model. Viruses. 2025; 17(3):341. https://doi.org/10.3390/v17030341

Shurtleff, Amy C., John C. Trefry, Sheri Dubey, Melek M. E. Sunay, Kenneth Liu, Ziqiang Chen, Michael Eichberg, Peter M. Silvera, Steve A. Kwilas, Jay W. Hooper, and et al. 2025. "rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model" Viruses 17, no. 3: 341. https://doi.org/10.3390/v17030341

Shurtleff, A. C., Trefry, J. C., Dubey, S., Sunay, M. M. E., Liu, K., Chen, Z., Eichberg, M., Silvera, P. M., Kwilas, S. A., Hooper, J. W., Martin, S., Simon, J. K., Coller, B.-A. G., & Monath, T. P. (2025). rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model. Viruses, 17(3), 341. https://doi.org/10.3390/v17030341